Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Arthritis, Rheumatoid (RA)”

818 trials

Showing 20 of 818 results

Testing effectiveness (Phase 2)Ended earlyNCT01569152
What this trial is testing

Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008)

Who this might be right for
Rheumatoid Arthritis (RA)
Merck Sharp & Dohme LLC 82
Post-approval studies (Phase 4)Study completedNCT02374021
What this trial is testing

Treatments Against RA and Effect on FDG-PET/CT

Who this might be right for
Arthritis, Rheumatoid
Brigham and Women's Hospital 159
Not applicableLooking for participantsNCT06108934
What this trial is testing

A Prospective, Pre-market, Multi-center Study of Insignia Hip Stem in THA to Determine Implant Survivorship and PROMS.

Who this might be right for
Arthritis (E.G., Degenerative Joint Disease (DJD), Osteoarthritis, and Rheumatoid Arthritis (RA))
Stryker Australia Pty Ltd. 313
Not applicableStudy completedNCT06718985
What this trial is testing

Impact of Bone Mineral Density on Fracture Risk Assessment in RA

Who this might be right for
Rheumatoid Arthritis
Istanbul Physical Medicine Rehabilitation Training and Research Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00280917
What this trial is testing

Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Can-Fite BioPharma 254
Testing effectiveness (Phase 2)Study completedNCT00747214
What this trial is testing

A Study Comparing CRx-102 Plus Disease-modifying Anti-rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in RA

Who this might be right for
Rheumatoid Arthritis
Zalicus 59
Not applicableNot Yet RecruitingNCT07367438
What this trial is testing

Effect of Subthreshold Stimulation on Fatigue in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
Beni-Suef University 84
Not applicableStudy completedNCT01579006
What this trial is testing

Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 184
Early research (Phase 1)WithdrawnNCT00717808
What this trial is testing

Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Imperial College London
Post-approval studies (Phase 4)Ended earlyNCT01661140
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate Dosage

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 427
Not applicableUnknownNCT03099525
What this trial is testing

Treatment Outcome and Prognostic Factors for Rheumatoid Arthritis (RA) Patients With Interstitial Lung Disease (ILD)

Who this might be right for
Rheumatoid ArthritisInterstitial Lung Disease
Hanyang University 600
Not applicableStudy completedNCT04079920
What this trial is testing

Predictors of Response to Tofacitinib Treatment in Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Pfizer 198
Not applicableStudy completedNCT05220423
What this trial is testing

Effectiveness of SMS Reminders on Influenza Vaccination Coverage in Patients With RA in the ART Registry

Who this might be right for
Rheumatoid Arthritis
Societe Francaise de Rhumatologie 446
Post-approval studies (Phase 4)Study completedNCT04157010
What this trial is testing

Tocilizumab REMission in Early RA

Who this might be right for
Rheumatoid Arthritis
University of Leeds 20
Not applicableStudy completedNCT01362062
What this trial is testing

Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 110
Post-approval studies (Phase 4)Study completedNCT01511003
What this trial is testing

A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)

Who this might be right for
Rheumatoid Arthritis
Astellas Pharma Inc 128
Not applicableStudy completedNCT00901550
What this trial is testing

The Chinese University of Hong Kong Early Arthritis Study

Who this might be right for
Rheumatoid Arthritis
Chinese University of Hong Kong 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07377773
What this trial is testing

QLS12010 in Participants With Moderate-to-severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
Qilu Pharmaceutical Co., Ltd. 180
Large-scale testing (Phase 3)Study completedNCT02332590
What this trial is testing

Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)

Who this might be right for
Rheumatoid Arthritis
Sanofi 369
Large-scale testing (Phase 3)Study completedNCT00110903
What this trial is testing

Treatment for Subjects With Active Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Amgen
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation